newsfilter
← Latest News
GlobeNewswire·

TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma

SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its